Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Fragile X Syndrome
NCT05120505Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Dec 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liquid metformin (Aspargo Labs) in Fragile X syndrome (FXS) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Aberrant Behavior Checklist at 6 months. Started Dec 2021; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT05120505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05120505.